News

18
Jun

Message from the President

Message from the President I am delighted to be joining CATALIS Québec in order to contribute to the development of clinical research in Quebec and to foster solidarity between all industry stakeholders to improve the care of patients suffering from currently incurable diseases. As the new President, I would like to take this opportunity to report on the exceptional and

Read more

16
Jun

Appointment of Dr. Michael Sebag to CATALIS Québec’s Board

Appointment of Dr. Michael Sebag to CATALIS Québec’s Board CATALIS Québec is pleased to announce that Dr. Michael Sebag will be joining its Board of Directors as of June 18, 2020. A researcher at the McGill University Health Centre (MUHC) since 2009, Dr. Sebag has participated in an impressive number of clinical studies which provided access to innovative treatments to

Read more

9
Jun

Appointment of Jacques Hendlisz as CATALIS Québec’s New Executive President

Appointment of Jacques Hendlisz as CATALIS Québec’s New Executive President CATALIS Quebec is proud to welcome Mr. Jacques Hendlisz to the organization as its new Executive President, effective April 1, 2020. Mr. Hendlisz is widely recognized for his extensive experience in the management of both research and hospital facilities. He served as the Douglas Institute’s Director General from 1994 to

Read more

27
May

COVID-19 and clinical trials : point of view of Rémi Quirion

In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Dr. Rémi Quirion, Chief Scientist of Quebec.  Q. How do you think the COVID-19 pandemic will alter current and future clinical

Read more

25
May

COVID-19 and clinical trials : point of view of Alan Bernstein

COVID-19 and clinical trials : point of view of Alan Bernstein In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Alan Bernstein, President and CEO, CIFAR. Q. How do you

Read more

20
May

International Clinical Trials’ Day: Clinical Research Saves Lives

International Clinical Trials’ Day: Clinical Research Saves Lives For the International Clinical Trials’ Day, CATALIS asked the leaders in the field: “Why is clinical research essential?“   “Clinical research exposes physicians and their teams to cutting-edge technologies that help to challenge and improve current care.”   “Clinical research is in the continuum of the innovation chain. Academic research laboratories are

Read more

18
May

COVID-19 and clinical trials : point of view of Dominique Johnson

COVID-19 and clinical trials : point of view of Dominique Johnson In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Dominique Johnson, General Manager, McPeak-Sirois Group for Clinical Research in

Read more

13
May

COVID-19 and clinical trials : point of view of Julie Autmizguine

COVID-19 and clinical trials : point of view of Julie Autmizguine In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Dr. Julie Autmizguine, Assistant Director of Clinical Research, Sainte-Justine UHC

Read more

11
May

COVID-19 and clinical trials : point of view of Luc Feldmann

COVID-19 and clinical trials : point of view of Luc Feldmann In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Luc Feldmann, Director, International Centre of Therapeutic Research, Servier Canada.

Read more

7
May

COVID-19 and clinical trials : point of view of Angela Genge

In light of the exceptional situation surrounding COVID-19, CATALIS interviewed clinical research leaders in Quebec to find out their perspectives on the crisis and to look for ways to adapt. The following statements detail the point of view of Dr. Angela Genge, Neurologist and Director, Clinical Research Unit, Montreal Neurological Institute-Hospital.